Founder Directory
Built by Keitoto
Founders2
Known for these resultsRole100%Role is parsed from founder titles in yc.db. Known for 100% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company0%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 0% of these rows have at least one match.School100%School is matched from bios, case-sensitive for acronyms. 100% of these rows have at least one match.
- Gabriel Ocana Santero@OcanaSanteroFounder/CEO · Exin TherapeuticsW25Healthcare · San Francisco
- Marko Tvrdic@markotvrdicFounder/COO · Exin TherapeuticsW25Healthcare · San Francisco
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Gabriel Ocana SanteroExin TherapeuticsFounder/CEOWinter 2025HealthcareSan Francisco, United States9https://x.com/OcanaSanteroMarko TvrdicExin TherapeuticsFounder/COOWinter 2025HealthcareSan Francisco, United States9https://x.com/markotvrdic
Showing 1–2 of 2 founders
Gabriel Ocana Santero
Founder/CEO·Exin Therapeutics
PRIMARY INFO
RoleFounder/CEO
Team size9
BatchWinter 2025
LocationSan Francisco, United States
Company statusActive
StageEarly
BIO
Neuroscientist with a background in biochemistry and research on gene therapy, pancreatic cancer, and muscle physiology at institutions in Boston, Vienna, and Stockholm. Earned MSc in Neuroscience and PhD in Pharmacology at Oxford Uni, focusing on neurodevelopment and the effects of SSRI anti-depressants on early patterns of neural activity. Used neuroAI models at the Gatsby Unit (UCL) to study serotonin’s role in cognition. Currently developing gene therapies for neurological conditions.
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
CredentialsPhD
DisciplineResearcherKeyword match from the bio text, not a classifier.
TRACK RECORD
First YC company on record
COMPANY CONTEXT
Exin TherapeuticsAI drug discovery platform for neurotherapeutics
IndustryHealthcare
Websiteexintherapeutics.com/
Team size9
LocationSan Francisco, United States
BatchWinter 2025
Co-foundersMarko Tvrdic@markotvrdic
